Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
iCAD history
iCAD company history timeline
iCAD was founded in 1984 as Howtek, Inc.
In 2001, foreseeing a decline in the graphic arts and photo finishing industries, Howtek elected to focus solely on the medical imaging market.
Swedish Covenant Hospital in Chicago offered Xoft’s Axxent Electronic Brachytherapy System treatment, beginning in 2008.
The shield used in the system had been cleared by the Food and Drug Administration (FDA) in June 2009 in an abbreviated process used for devices that are considered equivalent to products already on the market.
In December 2010, iCAD expanded the company’s oncology footprint by acquiring Xoft, Inc.
Starting in February, 2011, a series of parallel product liability suits have been filed in Orange Country Superior Court, totaling ten Jane Doe complainants and a number of John Doe spouses by August, 2011, per the September 30, 2011 10-Q filing by the company.
Full implications of the mistake had not been determined as of mid-March, 2011, but the company and the FDA had executed a recall on the FlexiShield Mini and were investigating.
In January 2013, an Inflection Point Investing stock analyst wrote in part, under "Risks": "Potential legal liability for a third-party related recall for a Xoft accessory product remains a small concern.
In April 2020, iCAD closed a registered direct offering for gross proceeds of ~$12.5 million.
In the first quarter of 2020, iCAD had a GAAP net loss of $11.8m, and a non-GAAP adjusted net loss of $3.9m.
Rate how well iCAD lives up to its initial vision.
iCAD jobs
Do you work at iCAD?
Is iCAD's vision a big part of strategic planning?
iCAD competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| ResMed | 1989 | $4.7B | 8,000 | 186 |
| Intersect ENT | 2003 | $106.7M | 393 | - |
| Tandem Diabetes Care | 2006 | $940.2M | 1,500 | 39 |
| Danaher | 1969 | $23.9B | 80,000 | 1,840 |
| Intuitive Surgical | 1995 | $8.4B | 5,527 | 321 |
| Amgen | 1980 | $33.4B | 22,000 | 728 |
| Beckman Coulter | 1935 | $3.7B | 12,000 | - |
| Seagen | 1997 | $2.0B | 900 | - |
| Ardent Technologies | - | $1.6M | 30 | - |
| Hologic | 1985 | $4.0B | 6,478 | 479 |
iCAD history FAQs
Zippia gives an in-depth look into the details of iCAD, including salaries, political affiliations, employee data, and more, in order to inform job seekers about iCAD. The employee data is based on information from people who have self-reported their past or current employments at iCAD. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by iCAD. The data presented on this page does not represent the view of iCAD and its employees or that of Zippia.
iCAD may also be known as or be related to ICAD INC, Icad, Icad, Inc., iCAD, iCAD Inc, iCAD Inc. and iCAD, Inc.